These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8015765)

  • 21. DNA content and S-phase fraction in epithelial ovarian cancer: what information do they really add?
    Braly P
    Gynecol Oncol; 1998 Oct; 71(1):1-2. PubMed ID: 9784311
    [No Abstract]   [Full Text] [Related]  

  • 22. Gene-expression profiling in epithelial ovarian cancer.
    Konstantinopoulos PA; Spentzos D; Cannistra SA
    Nat Clin Pract Oncol; 2008 Oct; 5(10):577-87. PubMed ID: 18648354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis.
    Lu L; Katsaros D; de la Longrais IA; Sochirca O; Yu H
    Cancer Res; 2007 Nov; 67(21):10117-22. PubMed ID: 17974952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberration of the PI3K/AKT/mTOR signaling in epithelial ovarian cancer and its implication in cisplatin-based chemotherapy.
    Zhang HY; Zhang PN; Sun H
    Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):81-6. PubMed ID: 19540648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival.
    Rosen DG; Wang L; Jain AN; Lu KH; Luo RZ; Yu Y; Liu J; Bast RC
    Clin Cancer Res; 2004 Oct; 10(19):6559-66. PubMed ID: 15475444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early events in ovarian oncogenesis.
    Cvetkovic D
    Reprod Biol Endocrinol; 2003 Oct; 1():68. PubMed ID: 14577833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular and biologic factors in the pathogenesis of ovarian cancer.
    Berek JS; Martínez-Maza O
    J Reprod Med; 1994 Apr; 39(4):241-8. PubMed ID: 8040839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer.
    Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Franklin J; Friedlander M; Andrews L
    Psychooncology; 2005 Apr; 14(4):249-61. PubMed ID: 15386771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of allelic imbalance on chromosome 17p13 in stage I and stage II epithelial ovarian cancers.
    Wiper DW; Zanotti KM; Kennedy AW; Belinson JL; Casey G
    Gynecol Oncol; 1998 Oct; 71(1):77-82. PubMed ID: 9784323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of glutathione S-transferase GSTM1 and GSTT1 null genotypes with clinical outcome in epithelial ovarian cancer.
    Howells RE; Redman CW; Dhar KK; Sarhanis P; Musgrove C; Jones PW; Alldersea J; Fryer AA; Hoban PR; Strange RC
    Clin Cancer Res; 1998 Oct; 4(10):2439-45. PubMed ID: 9796976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular biology of human ovarian cancer.
    Chow SN; Chien CH; Chen CT
    Int Surg; 1996; 81(2):152-7. PubMed ID: 8912082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer.
    Lu L; Katsaros D; Wiley A; Rigault de la Longrais IA; Puopolo M; Schwartz P; Yu H
    Gynecol Oncol; 2006 Dec; 103(3):990-5. PubMed ID: 16859738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk.
    Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2566-71. PubMed ID: 18086759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel 4-cM minimally deleted region on chromosome 11p15.1 associated with high grade nonmucinous epithelial ovarian carcinomas.
    Lu KH; Weitzel JN; Kodali S; Welch WR; Berkowitz RS; Mok SC
    Cancer Res; 1997 Feb; 57(3):387-90. PubMed ID: 9012461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Applications of molecular epidemiology to head and neck cancer.
    Hart TC
    Otolaryngol Clin North Am; 1997 Feb; 30(1):21-34. PubMed ID: 8995134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer.
    Wenham RM; Schildkraut JM; McLean K; Calingaert B; Bentley RC; Marks J; Berchuck A
    Clin Cancer Res; 2003 Oct; 9(12):4396-403. PubMed ID: 14555511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progression.
    Motamed-Khorasani A; Jurisica I; Letarte M; Shaw PA; Parkes RK; Zhang X; Evangelou A; Rosen B; Murphy KJ; Brown TJ
    Oncogene; 2007 Jan; 26(2):198-214. PubMed ID: 16832351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The C19007T polymorphism of ERCC1 and its correlation with the risk of epithelial ovarian and endometrial cancer in Korean women. A case control study.
    Jo H; Kang S; Kim SI; Kim JW; Park NH; Song YS; Park SY; Kang SB; Lee HP
    Gynecol Obstet Invest; 2007; 64(2):84-8. PubMed ID: 17314486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The unique characteristics of ovarian carcinogenesis in the adolescent and young adult population.
    Gibbon DG; Diaz-Arrastia C
    Semin Oncol; 2009 Jun; 36(3):250-7. PubMed ID: 19460582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.